Treatment with the drug is carried out under the control of indicators of immune status.
There are data on the effectiveness of use as an immunomodulator in the complex therapy of viral hepatitis, tuberculosis, pseudotuberculosis, influenza and acute respiratory viral infections, papillomatosis, sepsis.
According to clinical studies, the use in the acute period of the disease in the intestinal form of amoebiasis, typhoid fever, acute dysentery, erysipelas, diphtheria, brucellosis, hemorrhagic fever with renal syndrome improves the health of patients, promotes faster normalization of biochemical and immunological parameters.As a result of the use of the drug, the frequency of the occurrence of a prolonged recurrent course of diseases and the chronization of the process is reduced.
The use of infectious inflammatory and allergic etiology in bronchopulmonary diseases can shorten the duration of the disease, restore the activity of the immune system and prevent or significantly reduce the likelihood of complications.
According to clinical studies, the drug is successfully used in the complex therapy of bacterial, viral and fungal skin infections (pyoderma, furunculosis, erysipelas, papillomatosis, herpes), as well as in the treatment of atopic dermatitis.
In the medical literature, reports on the use of acute pancreatitis, peritonitis, in severe mechanical injuries, prolonged squeezing syndrome, burns, in the treatment and rehabilitation of patients after large cavitary operations have been published as part of a complex therapy.
Impact on the ability to drive vehicles and manage mechanisms
The drug does not affect the ability to drive vehicles and engage in other potentially hazardous activities,requiring increased concentration of attention and speed of psychomotor reactions.